Jordi Mestres, PhD

Affiliations: 
1985-1992 Departament de Química Universitat Autònoma de Barcelona, Barcelona, Spain 
 1992-1996 Institut de Química Computacional Universitat de Girona 
 1996-1997 Department of Computer-Aided Drug Design Pharmacia & Upjohn 
 1997-2000 Department of Molecular Design & Informatics N. V. Organon 
 2000-2003 Department of Chemistry Organon Laboratories 
 2003- Research Group on Biomedical Informatics IMIM Institut Hospital del Mar d'Investigacions Mèdiques 
Area:
Chemistry, Chemoinformatics, Drug Discovery
Google:
"Jordi Mestres"
Mean distance: (not calculated yet)
 

Parents

Sign in to add mentor
Joan Bertran grad student 1992-1996 Universitat Autònoma de Barcelona
 (PhD Thesis entitled "Structural, electronic and mechanistic aspects of hydrogen (h-/h./h+) transfers. From the simplest model to the enzymic and non-enzymic processes". Universitat de Girona, 1996.)
Miquel Duran grad student 1992-1996 Universitat de Girona
 (PhD Thesis entitled "Structural, electronic and mechanistic aspects of hydrogen (h-/h./h+) transfers. From the simplest model to the enzymic and non-enzymic processes". Universitat de Girona, 1996.)
Gerald M. Maggiora post-doc 1996-1997 Pharmacia & Upjohn
 (Post-doctoral researcher at Pharmacia & Upjohn, Kalamazoo (MI), USA)
Ramon Carbó-Dorca research scientist 1992-1996 Universitat de Girona
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Jalencas X, Berg H, Espeland LO, et al. (2024) Design, quality and validation of the EU-OPENSCREEN fragment library poised to a high-throughput screening collection. Rsc Medicinal Chemistry. 15: 1176-1188
Mestres J, Martinez-Sevillano M, Falaguera MJ. (2023) CIPSI: an open chemical intellectual property service for medicinal chemists. Molecular Informatics
Montes-Grajales D, Garcia-Serna R, Mestres J. (2023) Impact of the COVID-19 pandemic on the spontaneous reporting and signal detection of adverse drug events. Scientific Reports. 13: 18817
Falaguera MJ, Mestres J. (2023) Illuminating the Chemical Space of Untargeted Proteins. Journal of Chemical Information and Modeling. 63: 2689-2698
Bajorath J, Chávez-Hernández AL, Duran-Frigola M, et al. (2022) Chemoinformatics and artificial intelligence colloquium: progress and challenges in developing bioactive compounds. Journal of Cheminformatics. 14: 82
Galyan SM, Ewald CY, Jalencas X, et al. (2022) Fragment-based virtual screening identifies a first-in-class preclinical drug candidate for Huntington's disease. Scientific Reports. 12: 19642
Faria M, Bellot M, Bedrossiantz J, et al. (2022) Environmental levels of carbaryl impair zebrafish larvae behaviour: The potential role of ADRA2B and HTR2B. Journal of Hazardous Materials. 431: 128563
Gray B, Baruteau AE, Antolin AA, et al. (2022) Rare Variation in Drug Metabolism and Long QT Genes and the Genetic Susceptibility to Acquired Long QT Syndrome. Circulation. Genomic and Precision Medicine. CIRCGEN121003391
Zahoránszky-Kőhalmi G, Siramshetty VB, Kumar P, et al. (2022) A Workflow of Integrated Resources to Catalyze Network Pharmacology Driven COVID-19 Research. Journal of Chemical Information and Modeling
Falaguera MJ, Mestres J. (2021) Congenericity of Claimed Compounds in Patent Applications. Molecules (Basel, Switzerland). 26
See more...